State ID
Clinical Trials in Idaho
Idaho is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Idaho and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Idaho
Clostridioides Difficile Infection (2)Acute Respiratory Distress Syndrome (ARDS) (2)ARDS (2)ARDS (Acute Respiratory Distress Syndrome) (2)Acute Respiratory Distress Syndrome (2)Stage IIIB Lung Cancer AJCC v8 (2)Small Lymphocytic Lymphoma (2)Acute Myeloid Leukemia (1)Pleural Biphasic Mesothelioma (1)Pleural Sarcomatoid Mesothelioma (1)Clostridium Difficile (1)Clostridium Difficile Infections (1)
Frequently Asked Questions — Clinical Trials in Idaho
How many clinical trials are currently recruiting in Idaho?
ClinicalMetric currently tracks 41 actively recruiting clinical trials with at least one location in Idaho. The total number of registered studies—including active but not currently enrolling trials—is 41. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Idaho?
Idaho hosts clinical trials across a broad range of medical conditions, including Clostridioides Difficile Infection, Acute Respiratory Distress Syndrome (ARDS), ARDS, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Idaho serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Idaho?
To join a clinical trial in Idaho, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Idaho maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Idaho
NCT07154706 Phase 3
Recruiting
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positiv...
Condition
Non-small Cell Lung Cancer (NSCLC)
Enrollment
180 pts
Location
United States, Canada, China
Sponsor
Nuvation Bio Inc.
NCT06703073 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
600 pts
Location
United States
Sponsor
PPD Development, LP
NCT06806033 Phase 2
Recruiting
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile fo...
Condition
B-Cell Non-Hodgkins Lymphoma
Enrollment
100 pts
Location
United States, Australia, Canada
Sponsor
Hoffmann-La Roche
NCT05219617 Phase 3
Recruiting
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizu...
Condition
Seizures
Enrollment
252 pts
Location
United States, Argentina, Australia
Sponsor
SK Life Science, Inc.
NCT06888141 N/A
Recruiting
Stress Management for College Students
Condition
Distress, Emotional
Enrollment
500 pts
Location
United States
Sponsor
Boise State University
NCT03053141 N/A
Recruiting
RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)
Condition
Cardiac Arrythmias
Enrollment
100 pts
Location
United States, Italy, Monaco
Sponsor
Boston Scientific Corporation
NCT04628767 Phase 2, Phase 3
Recruiting
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for...
Condition
Renal Pelvis and Ureter Urothelial Carcinoma
Enrollment
131 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT03550391 Phase 3
Recruiting
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radioth...
Condition
Brain Metastases
Enrollment
206 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
NCT06851559 Phase 2
Recruiting
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to ...
Condition
Eosinophilic Esophagitis
Enrollment
80 pts
Location
United States
Sponsor
Phathom Pharmaceuticals, Inc.
NCT05561387 Phase 3
Recruiting
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM)...
Condition
Plasma Cell Myeloma
Enrollment
510 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT07283939 N/A
Recruiting
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned...
Condition
Ampulla of Vater Carcinoma
Enrollment
420 pts
Location
United States, Puerto Rico
Sponsor
Alliance for Clinical Trials i
NCT06096844 Phase 3
Recruiting
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Ad...
Condition
Advanced Lung Non-Small Cell Carcinoma
Enrollment
304 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04269902 Phase 3
Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia...
Condition
Chronic Lymphocytic Leukemia
Enrollment
247 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT05879926 Phase 3
Recruiting
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression...
Condition
Breast Cancer
Enrollment
3,960 pts
Location
United States, Canada, Colombia
Sponsor
NRG Oncology
NCT02559778 Phase 2
Recruiting
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Condition
Neuroblastoma
Enrollment
500 pts
Location
United States, Canada
Sponsor
Giselle Sholler
NCT06841354 Phase 3
Recruiting
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Comb...
Condition
Triple Negative Breast Neoplasms
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
Page 2 of 2 — 41 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology